Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Peripherally inserted central catheter Stories

2014-03-13 12:28:50

Growing Adoption of Premium-Priced Safety and Antimicrobial Devices Will Support Revenue Growth, According to Findings from Decision Resources Group BURLINGTON, Mass., March 13, 2014 /PRNewswire/ -- Decision Resources Group finds that the United States vascular access device market will grow moderately to reach a value surpassing $2 billion by 2022. Market expansion will be supported by rising adoption of premium-priced safety and antimicrobial devices in the wake of concerns regarding...

2013-12-19 23:04:33

Companies in the Venous Access Device Manufacturing industry will consolidate, supporting industry growth, with smaller firms benefiting from greater R&D budgets, and over the next five years, manufacturers will continue to invest in innovation and new products to target complicated needs. For these reasons, industry research firm IBISWorld has added a report on the Venous Access Device Manufacturing industry to its growing industry report collection. New York, NY (PRWEB) December 19,...

2013-09-25 23:20:20

Reportbuyer.com just published a new market research report: Brazilian Vascular Access Devices Market. London (PRWEB) September 25, 2013 In 2012, the vascular access device market in Brazil was valued at nearly $59 million. The vascular access device market includes implantable ports, port (Huber) needles, dialysis catheters and peripherally inserted central catheters (PICCs). Brazil has the largest private health insurance market in Latin America. The expansion of private health...

2013-08-07 10:31:55

Study shows peripherally inserted central catheters have similar CLABSI risk in vulnerable patients A new study reports that peripherally inserted central catheters (PICCs) do not reduce the risk of central line associated bloodstream infections (CLABSIs) in hospitalized patients. PICCs have become one of the most commonly used central venous catheters (CVCs) in healthcare settings since they are considered easier and safer to use, with less risk of CLABSIs. The study, published in the...

2013-08-02 23:04:18

A California InventHelp client has invented the Clear Bandage Protector, which is being submitted to companies for review. PITTSBURGH, PA (PRWEB) August 02, 2013 "While going through chemotherapy, I observed the archaic nature of the bandage-protection method that is used by the nurses," said a concerned inventor from Lake Forest, Calif., "so I decided that there had to be an easier way to protect the existing dressing in a single strip of plastic with some adhesion on the...

2013-05-20 13:45:15

U-M study finds peripherally inserted central catheters -- an often preferred route for delivery of IV medications -- increase risk of blood clots in sickest patients Touted for safety, ease and patient convenience, peripherally inserted central catheters have become many clinicians' go-to for IV delivery of antibiotics, nutrition, chemotherapy, and other medications. But compared to other central venous catheters (CVCs), these commonly-used catheters (known as PICCs) more than double...

2013-03-19 10:01:29

Location, location, location. A new Johns Hopkins Children's Center study shows the real-estate mantra also holds true when it comes to choosing correct catheter placement in children. The research findings, described online March 18 in JAMA Pediatrics, show that catheters in children inserted in a vessel in the arm or leg and not threaded into a large vein near the heart are nearly four times as likely to dislodge, cause vein inflammation or dangerous blood clots as are catheters advanced...

2013-01-24 12:26:54

SWINDON, England, January 24, 2013 /PRNewswire/ -- Vygon (UK) Ltd has launched an innovative new ECG product designed to help reduce both the patients' and clinicians' exposure to X-ray radiation and enhance therapy. Nautilus(R) [http://www.vygon.co.uk/products/group/piccs ] helps you find your way during catheter insertion by providing accurate, real-time tip location confirmation. (Photo: http://photos.prnewswire.com/prnh/20130123/589298 ) Thousands of peripherally...

2012-05-15 02:29:26

MISSISSAUGA, ON, May 15, 2012 /PRNewswire/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced United States Food and Drug Administration ("FDA") approval of IV Clear(TM), a breakthrough antimicrobial silicone adhesive film dressing designed for securing vascular intravenous access devices. Covalon's IV Clear antimicrobial film dressings have a number of unique and highly desirable characteristics:...

2011-04-12 06:45:00

New Catheter Placement Technologies Fuel Bedside Nurse PICC Placement Procedures VANCOUVER, April 12 /PRNewswire/ - According to a new report by iData Research (www.idataresearch.net), the leading global authority in medical device market research, the U.S. vascular access device market will reach over $4.8 billion by 2017, fueled by the adoption of new antimicrobial technologies for central venous catheters (CVCs), dialysis catheters, peripherally inserted central catheters (PICCs)...


Latest Peripherally inserted central catheter Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

More Articles (1 articles) »